Promising benefit of resveratrol in preventing preterm birth: A systematic review
- Authors:
- Muhammad Habiburrahman
- Muhammad Ilham Dhiya Rakasiwi
- Afid Brilliana Putra
-
Affiliations: Faculty of Medicine, Universitas Indonesia, Central Jakarta, DKI Jakarta 10430, Indonesia - Published online on: January 22, 2024 https://doi.org/10.3892/wasj.2024.225
- Article Number: 10
-
Copyright : © Habiburrahman et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
 |
|
World Health Organization (WHO): Factsheet of Preterm Birth. WHO, Geneva, 2018. https://www.who.int/news-room/fact-sheets/detail/preterm-birth. | |
|
Pan American Health Organization (PAHO): 152 million babies born preterm in the last decade. PAHO, Washington, DC, 2013. https://www.paho.org/en/news/15-6-2023-152-million-babies-born-preterm-last-decade#:~:text=An%20estimated%2013.4%20million%20babies,37%20weeks%20of%20pregnancy)%20worldwide. Accessed Sep 28, 2023. | |
|
Cao G, Liu J and Liu M: Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019. JAMA Pediatr. 176(787)2022.PubMed/NCBI View Article : Google Scholar | |
|
Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J and Oei JL: New South Wales and Australian Capital Territory Neonatal Intensive Care Units' Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics. 133:55–62. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Beam AL, Fried I, Palmer N, Agniel D, Brat G, Fox K, Kohane I, Sinaiko A, Zupancic JAF and Armstrong J: Estimates of healthcare spending for preterm and low-birthweight infants in a commercially insured population: 2008-2016. J Perinatol. 40:1091–1099. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Romero R, Dey SK and Fisher SJ: Preterm labor: One syndrome, many causes. Science. 345:760–765. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Bastek JA, Gómez LM and Elovitz MA: The role of inflammation and infection in preterm birth. Clin Perinatol. 38:385–406. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Bariani MV, Correa F, Leishman E, Domínguez Rubio AP, Arias A, Stern A, Bradshaw HB and Franchi AM: Resveratrol protects from lipopolysaccharide-induced inflammation in the uterus and prevents experimental preterm birth. Mol Hum Reprod. 23:571–581. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Tency I: Inflammatory response in maternal serum during preterm labour. Facts Views Vis Obgyn. 6:19–30. 2014.PubMed/NCBI | |
|
Elovitz MA, Wang Z, Chien EK, Rychlik DF and Phillippe M: A new model for Inflammation-Induced preterm birth. Am J Pathol. 163:2103–2111. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Deng W, Cha J, Yuan J, Haraguchi H, Bartos A, Leishman E, Viollet B, Bradshaw HB, Hirota Y and Dey SK: p53 coordinates decidual sestrin 2/AMPK/mTORC1 signaling to govern parturition timing. J Clin Invest. 126:2941–2954. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Simhan HN and Caritis SN: Prevention of preterm delivery. N Engl J Med. 357:477–487. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Abramovici A, Cantu J and Jenkins SM: Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am. 39:77–87. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Alfirevic Z: Tocolytics: Do they actually work? BMJ. 345:e6531. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Croen LA, Connors SL, Matevia M, Qian Y, Newschaffer C and Zimmerman AW: Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders. J Neurodev Disord. 3:307–315. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Gidaya NB, Lee BK, Burstyn I, Michael Y, Newschaffer CJ and Mortensen EL: In utero exposure to β-2-Adrenergic receptor agonist drugs and risk for autism spectrum disorders. Pediatrics. 137(e20151316)2016.PubMed/NCBI View Article : Google Scholar | |
|
Furuya H, Taguchi A, Kawana K, Yamashita A, Inoue E, Yoshida M, Nakamura H, Fujimoto A, Inoue T, Sato M, et al: Resveratrol protects against pathological preterm birth by suppression of Macrophage-Mediated Inflammation. Reprod Cie. 22:1561–1568. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Bourque SL, Dolinsky VW, Dyck JRB and Davidge ST: Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta. 33:449–452. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Poudel R, Stanley JL, Rueda-Clausen CF, Andersson IJ, Sibley CP, Davidge ST and Baker PN: Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus. PLoS One. 8(e64401)2013.PubMed/NCBI View Article : Google Scholar | |
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar | |
|
Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, Hartung T and Hoffmann S: ‘ToxRTool’, a new tool to assess the reliability of toxicological data. Toxicol Lett. 189:138–144. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Valenti C, Billi M, Pancrazi GL, Calabria E, Armogida NG, Tortora G, Pagano S, Barnaba P and Marinucci L: Biological effects of cannabidiol on human cancer cells: Systematic review of the literature. Pharmacol Res. 181(106267)2022.PubMed/NCBI View Article : Google Scholar | |
|
Moser VC, Morris-Schaffer K, Richardson JR and Li AA: Glyphosate and neurological outcomes: A systematic literature review of animal studies. J Toxicol Environ Health B Crit Rev. 25:162–209. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Gupta M, Singh D, Rastogi S, Siddique HR, Al-Dayan N, Ahmad A, Sikander M and Sarwat M: Anti-cancer activity of guggulsterone by modulating apoptotic markers: A systematic review and meta-analysis. Front Pharmacol. 14(1155163)2023.PubMed/NCBI View Article : Google Scholar | |
|
EU Science Hub: ToxRTool-Toxicological data reliability assessment tool. In: European Commission for Scientific Tools and Databases. European Commission, 2023. https://joint-research-centre.ec.europa.eu/scientific-tools-and-databases/toxrtool-toxicological-data-reliability-assessment-tool_en. Accessed Sep 21, 2023. | |
|
University of Pittsburgh: Health Research Reporting Guidelines, Study Execution Manuals, Critical Appraisal, Risk of Bias, and Non-reporting Biases: From Cochrane Handbook for Systematic Reviews of Interventions [Internet]. University of Pittsburgh: Health Sciences Library System Guides, 2023. https://hsls.libguides.com/reporting-study-tools/risk-of-bias. Accessed Sep 21, 2023. | |
|
Osmanovic A, Halilovic S, Kurtovic-Kozaric A and Hadziabdic N: Evaluation of periodontal ligament cell viability in different storage media based on human PDL cell culture experiments-A systematic review. Dental Traumatol. 34:384–393. 2018.PubMed/NCBI View Article : Google Scholar | |
|
National Toxicology Program: Handbook for conducting a literature-based health assessment using OHAT approach for systemic review and evidence integration. National Institute of Environmental Health Science, pp1-102, 2019. | |
|
Puidokas T, Kubilius M, Stumbras A and Juodzbalys G: Effect of leukocytes included in platelet concentrates on cell behaviour. Platelets. 30:937–945. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Center for Evidence-Based Medicine (CEBM): OCEMB Levels of Evidence. CEBM, Oxford, 2011. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Accessed Sep 21, 2023. | |
|
Novaković R, Radunović N, Marković-Lipkovski J, Ćirović S, Beleslin-Čokić B, Ilić B, Ivković B, Heinle H, Živanović V and Gojković-Bukarica LJ: Effects of the polyphenol resveratrol on contractility of human term pregnant myometrium. Mol Hum Reprod. 21:545–551. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A, Chou D, Oladapo OT, et al: Tocolytics for delaying preterm birth: A network meta-analysis. Cochrane Database Syst Rev. 8(CD014978)2022.PubMed/NCBI View Article : Google Scholar | |
|
Abd El-Mohsen M, Bayele H, Kuhnle G, Gibson G, Debnam E, Kaila Srai S, Rice-Evans C and Spencer JP: Distribution of [3H]trans-resveratrol in rat tissues following oral administration. Br J Nutr. 96:62–70. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Walle T, Hsieh F, DeLegge MH, Oatis JE and Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 32:1377–1382. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Walle T: Bioavailability of resveratrol. Ann N Y Acad Sci. 1215:9–15. 2011.PubMed/NCBI View Article : Google Scholar | |
|
la Porte C, Voduc N, Zhang G, Seguin I, Tardiff D, Singhal N and Cameron DW: Steady-State pharmacokinetics and tolerability of Trans-Resveratrol 2000 mg twice daily with food, quercetin and alcohol (Ethanol) in healthy human subjects. Clin Pharmacokinet. 49:449–454. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, et al: Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the Insulin-like growth factor axis. Cancer Res. 70:9003–9011. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Gracie S, Pennell C, Ekman-Ordeberg G, Lye S, McManaman J, Williams S, Palmer L, Kelley M, Menon R and Gravett M: PREBIC ‘-Omics’ Research Group. An integrated systems biology approach to the study of preterm birth using ‘-omic’ technology-a guideline for research. BMC Pregnancy Childbirth. 11(71)2011.PubMed/NCBI View Article : Google Scholar | |
|
Green ES and Arck PC: Pathogenesis of preterm birth: Bidirectional inflammation in mother and fetus. Semin Immunopathol. 42:413–429. 2020.PubMed/NCBI View Article : Google Scholar | |
|
McCarthy R, Martin-Fairey C, Sojka DK, Herzog ED, Jungheim ES, Stout MJ, Fay JC, Mahendroo M, Reese J, Herington JL, et al: Mouse models of preterm birth: Suggested assessment and reporting guidelines. Biol Reprod. 99:922–937. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Romero R and Tartakovsky B: The natural interleukin-1 receptor antagonist prevents interleukin-l-induced preterm delivery in mice. Am J Obstet Gynecol. 167:1041–1045. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Robertson SA, Christiaens I, Dorian CL, Zaragoza DB, Care AS, Banks AM and Olson DM: Interleukin-6 is an essential determinant of on-time parturition in the mouse. Endocrinology. 151:3996–4006. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Montalbano AP, Hawgood S and Mendelson CR: Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2 manifest delayed parturition and decreased expression of inflammatory and contractile genes. Endocrinology. 154:483–498. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Gonzalez JM, Franzke CW, Yang F, Romero R and Girardi G: Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. Am J Pathol. 179:838–849. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wahid HH, Dorian CL, Chin PY, Hutchinson MR, Rice KC, Olson DM, Moldenhauer LM and Robertson SA: Toll-Like Receptor 4 Is an essential upstream regulator of On-Time parturition and perinatal viability in mice. Endocrinology. 156:3828–3841. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SBEA, Fleer A, Ruven HJ and Rijkers GT: Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res. 62:474–476. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Bayar E, Bennett PR, Chan D, Sykes L and MacIntyre DA: The pregnancy microbiome and preterm birth. Semin Immunopathol. 42:487–499. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R and Conner M: Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial. Am J Obstet Gynecol. 194:617–623. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Abedini E, Khodadadi E, Zeinalzadeh E, Moaddab SR, Asgharzadeh M, Mehramouz B, Dao S and Samadi Kafil H: A comprehensive study on the antimicrobial properties of resveratrol as an alternative therapy. Evid Based Complement Alternat Med. 2021(8866311)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ma DSL, Tan LTH, Chan KG, Yap WH, Pusparajah P, Chuah LH, Ming LC, Khan TM, Lee LH and Goh BH: Resveratrol-Potential antibacterial agent against foodborne pathogens. Front Pharmacol. 9(102)2018.PubMed/NCBI View Article : Google Scholar | |
|
Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EMG, Doorn JA and Slikker W: Nitrative and oxidative stress in toxicology and disease. Toxicol Sci. 112:4–16. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Meng T, Xiao D, Muhammed A, Deng J, Chen L and He J: Anti-Inflammatory action and mechanisms of resveratrol. Molecules. 26(229)2021.PubMed/NCBI View Article : Google Scholar | |
|
Gómez-Chávez F, Correa D, Navarrete-Meneses P, Cancino-Diaz JC, Cancino-Diaz ME and Rodríguez-Martínez S: NF-κB and its regulators during pregnancy. Front Immunol. 12(679106)2021.PubMed/NCBI View Article : Google Scholar | |
|
Malaguarnera. Influence of resveratrol on the immune response. Nutrients. 11(946)2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB signaling in inflammation. Signal Transduct Target Ther. 2(17023)2017.PubMed/NCBI View Article : Google Scholar | |
|
Klawitter M, Hakozaki M, Kobayashi H, Krupkova O, Quero L, Ospelt C, Gay S, Hausmann O, Liebscher T, Meier U, et al: Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells. Eur Spine J. 23:1878–1891. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Lappas M, Mitton A, Lim R, Barker G, Riley C and Permezel M: SIRT1 Is a novel regulator of key pathways of human labor1. Biol Reprod. 84:167–178. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Manna SK, Mukhopadhyay A and Aggarwal BB: Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol. 164:6509–6519. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H and Qiu J: Activation of sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One. 6(e27081)2011.PubMed/NCBI View Article : Google Scholar | |
|
Taguchi A, Yamashita A, Kawana K, Nagamatsu T, Furuya H, Inoue E, Osuga Y and Fujii T: Recent progress in therapeutics for inflammation-associated preterm birth: A review. Reprod Sci. 24:7–18. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Taguchi A, Wada-Hiraike O, Kawana K, Koga K, Yamashita A, Shirane A, Urata Y, Kozuma S, Osuga Y and Fujii T: Resveratrol suppresses inflammatory responses in endometrial stromal cells derived from endometriosis: A possible role of the sirtuin 1 pathway. J Obstet Gynaecol Res. 40:770–778. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Vidal MS, Lintao RCV, Severino MEL, Tantengco OAG and Menon R: Spontaneous preterm birth: Involvement of multiple feto-maternal tissues and organ systems, differing mechanisms, and pathways. Front Endocrinol (Lausanne). 13(1015622)2022.PubMed/NCBI View Article : Google Scholar | |
|
Wood EM, Hornaday KK and Slater DM: Prostaglandins in biofluids in pregnancy and labour: A systematic review. PLoS One. 16(e0260115)2021.PubMed/NCBI View Article : Google Scholar | |
|
Yamashita A, Kawana K, Tomio K, Taguchi A, Isobe Y, Iwamoto R, Masuda K, Furuya H, Nagamatsu T, Nagasaka K, et al: Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. Sci Rep. 3(3113)2013.PubMed/NCBI View Article : Google Scholar | |
|
Li WJ, Lu JW, Zhang CY, Wang WS, Ying H, Myatt L and Sun K: PGE2 vs PGF2α in human parturition. Placenta. 104:208–219. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Dias S, Jones LV, Navaratnam K and Caldwell DM: Labour induction with prostaglandins: A systematic re view and network meta-analysis. BMJ. 350(h217)2015.PubMed/NCBI View Article : Google Scholar | |
|
Sykes L, MacIntyre DA, Teoh TG and Bennett PR: Anti-inflammatory prostaglandins for the prevention of preterm labour. Reproduction. 148:R29–R40. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF and Petraglia F: Inflammation and Pregnancy. Reprod Sci. 16:206–215. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, et al: Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science. 348(aaa2340)2015.PubMed/NCBI View Article : Google Scholar | |
|
Mitchell MD, Rice GE, Vaswani K, Kvaskoff D and Peiris HN: Differential regulation of eicosanoid and endocannabinoid production by inflammatory mediators in human choriodecidua. PLoS One. 11(e0148306)2016.PubMed/NCBI View Article : Google Scholar | |
|
Maia J, Fonseca B, Teixeira N and Correia-da-Silva G: The fundamental role of the endocannabinoid system in endometrium and placenta: Implications in pathophysiological aspects of uterine and pregnancy disorders. Hum Reprod Update. 26:586–602. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Nallendran V, Lam PM, Marczylo TH, Bankart MJ, Taylor AH, Taylor DJ and Konje JC: The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour. BJOG. 117:863–869. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Bariani MV, Domínguez Rubio AP, Cella M, Burdet J, Franchi AM and Aisemberg J: Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor. Reproduction. 150:463–472. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Komarnytsky S, Rathinasabapathy T, Wagner C, Metzger B, Carlisle C, Panda C, Le Brun-Blashka S, Troup JP and Varadharaj S: Endocannabinoid system and its regulation by polyunsaturated fatty acids and full spectrum hemp oils. Int J Mol Sci. 22(5479)2021.PubMed/NCBI View Article : Google Scholar | |
|
Rava A and Trezza V: Emerging roles of endocannabinoids as key lipid mediators for a successful pregnancy. Int J Mol Sci. 24(5220)2023.PubMed/NCBI View Article : Google Scholar | |
|
Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T and Morrison JJ: Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol. 190:2–9. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Mitchell MD, Sato TA, Wang A, Keelan JA, Ponnampalam AP and Glass M: Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism. Am J Physiol Endocrinol Metab. 294:E352–E356. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Kozakiewicz ML, Grotegut CA and Howlett AC: Endocannabinoid system in pregnancy maintenance and labor: A mini-review. Front Endocrinol (Lausanne). 12(699951)2021.PubMed/NCBI View Article : Google Scholar | |
|
Booker L, Kinsey SG, Abdullah RA, Blankman JL, Long JZ, Ezzili C, Boger DL, Cravatt BF and Lichtman AH: The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. Br J Pharmacol. 165:2485–2496. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Sun X, Deng W, Li Y, Tang S, Leishman E, Bradshaw HB and Dey SK: Sustained endocannabinoid signaling compromises decidual function and promotes inflammation-induced preterm birth. J Biol Chem. 291:8231–8240. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG and Lichtman AH: The endogenous cannabinoid system: A budding source of targets for treating inflammatory and neuropathic pain. Neuropsychopharmacology. 43:52–79. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Connor M, Vaughan CW and Vandenberg RJ: N-Acyl amino acids and N-acyl neurotransmitter conjugates: Neuromodulators and probes for new drug targets. Br J Pharmacol. 160:1857–1871. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Godlewski G, Offertáler L, Osei-Hyiaman D, Mo FM, Harvey-White J, Liu J, Davis MI, Zhang L, Razdan RK, Milman G, et al: The endogenous brain constituent N-Arachidonoyl l-Serine Is an activator of large conductance Ca 2+-Activated K+ channels. J Pharmacol Exp Ther. 328:351–361. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Guo J, Williams DJ and Ikeda SR: N-Arachidonoyl L-Serine, a putative endocannabinoid, alters the activation of N-Type Ca2+ Channels in sympathetic neurons. J Neurophysiol. 100:1147–151. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Grazia Cascio M, Minassi A, Ligresti A, Appendino G, Burstein S and Di Marzo V: A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun. 314:192–196. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Bachkangi P, Taylor AH, Bari M, Maccarrone M and Konje JC: Prediction of preterm labour from a single blood test: The role of the endocannabinoid system in predicting preterm birth in high-risk women. Eur J Obstet Gynecol Reprod Biol. 243:1–6. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Deutsch DG: A personal retrospective: Elevating anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs). Front Pharmacol. 7(370)2016.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Bátkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, Gao B and Kunos G: Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J Biol Chem. 278:45034–45039. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Nagarkatti P, Pandey R, Rieder SA, Hegde VL and Nagarkatti M: Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 1:1333–1349. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C and Finazzi-Agrò A: Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 355:1326–1329. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Dong C, Chen J, Harrington A, Vinod KY, Hegde ML and Hegde VL: Cannabinoid exposure during pregnancy and its impact on immune function. Cell Mol Life Sci. 76:729–743. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hirota Y, Cha J, Yoshie M, Daikoku T and Dey SK: Heightened uterine mammalian target of rapamycin complex 1 (mTORC1) signaling provokes preterm birth in mice. Proc Natl Acad Sci USA. 108:18073–18078. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wolfson ML, Aisemberg J, Correa F and Franchi AM: Peripheral blood mononuclear cells infiltration downregulates decidual FAAH activity in an LPS-Induced embryo resorption model. J Cell Physiol. 232:1441–1447. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Cox LS and Redman C: The role of cellular senescence in ageing of the placenta. Placenta. 52:139–145. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Singh M, Parent S, Leblanc V and Asselin E: Resveratrol modulates the expression of PTGS2 and cellular proliferation in the normal rat endometrium in an AKT-Dependent Manner1. Biol Reprod. 84:1045–1052. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Rajkovic J, Djokic V, Gostimirovic M, Gojkovic-Bukarica L, Martorell M, Sharifi-Rad J and Novakovic R: Potassium channels on smooth muscle as a molecular target for plant-derived Resveratrol. Cell Mol Biol (Noisy-le-Grand). 66:133–144. 2020.PubMed/NCBI | |
|
Carreiro JN, Magnani M, Jobling P, van Helden DF, Nalivaiko E and Braga VA: Resveratrol restores uterine contractions during hypoxia by blockade of ATP-sensitive potassium channels. J Funct Foods. 33:307–313. 2017. | |
|
Lim R, Barker G and Lappas M: Activation of AMPK in human fetal membranes alleviates infection-induced expression of pro-inflammatory and pro-labour mediators. Placenta. 36:454–462. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Novakovic R, Ilic B, Beleslin-Cokic B, Radunovic N, Heinle H, Scepanovic R and Gojkovic-Bukarica L: The effect of resveratrol on contractility of non-pregnant rat uterus: The contribution of K(+) channels. J Physiol Pharmacol. 64:795–805. 2013.PubMed/NCBI | |
|
Okawa T, Longo M, Vedernikov YP, Chwalisz K, Saade GR and Garfield RE: Role of nucleotide cyclases in the inhibition of pregnant rat uterine contractions by the openers of potassium channels. Am J Obstet Gynecol. 182:913–918. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Brainard AM, Korovkina VP and England SK: Potassium channels and uterine function. Semin Cell Dev Biol. 18:332–339. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Zheng S, Feng Q, Cheng J and Zheng J: Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications. Biosci Rep. 38(BSR20171741)2018.PubMed/NCBI View Article : Google Scholar | |
|
Azachi M, Yatuv R, Katz A, Hagay Y and Danon A: A novel red grape cells complex: Health effects and bioavailability of natural resveratrol. Int J Food Sci Nutr. 65:848–855. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wang P and Sang S: Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors. 44:16–25. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Pollack RM and Crandall JP: Resveratrol: Therapeutic potential for improving cardiometabolic health. Am J Hypertens. 26:1260–1268. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Shrikanta A, Kumar A and Govindaswamy V: Resveratrol content and antioxidant properties of underutilized fruits. J Food Sci Technol. 52:383–390. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P and Gallelli L: Quercetin, Epigallocatechin gallate, curcumin, and resveratrol: From dietary sources to human MicroRNA modulation. Molecules. 25(63)2019.PubMed/NCBI View Article : Google Scholar | |
|
Weiskirchen S and Weiskirchen R: Resveratrol: How much wine do you have to drink to stay healthy? Adv Nutr. 7:706–718. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kuršvietienė L, Stanevičienė I, Mongirdienė A and Bernatonienė J: Multiplicity of effects and health benefits of resveratrol. Medicina (Kaunas). 52:148–155. 2016.PubMed/NCBI View Article : Google Scholar |
